香砂六君子汤对胃癌化疗术后脾胃虚弱证的临床疗效

Clinical efficacy of the Xiangsha Liujunzi decoction on the Piwei Xuruo syndrome after chemotherapy of gastric cancer

目的:探讨香砂六君子汤对胃癌化疗术后脾胃虚弱证的临床疗效。方法:将本院50例胃癌患者随机分为两组作为研究对象(收治时间:2014年2月-2016年1月),每组25例。对照组实施常规西药治疗,观察组给予香砂六君子汤治疗。对比两组胃癌患者的治疗效果、T细胞亚群数量以及临床症状评分。结果:观察组胃癌患者的临床总有效率、治疗后的NK细胞和CD4+/CD8+数量以及临床症状评分与对照组患者相比均更占优势(P<0.05)。结论:使用香砂六君子汤治疗胃癌化疗术后脾胃虚弱证的临床疗效令人满意。

Objective:To explore the clinical effect of the Xiangsha Liujunzi decoction on the Piwei Xuruo syndrome after chemotherapy of gastric cancer.Methods:50patients were divided into two groups,25cases in each group.The control group was treated with western medicine;and the observation group was treated with the Xiangsha liujunzi decoction.Results:The efficacy,NK cell and CD4+/CD8+were higher in the observation group than the control group(P<0.05).Conclusion:The Xiangsha Liujunzi decoction is effective on the Piwei Xuruo syndrome after chemotherapy of gastric cancer.